A Study on the Immune Response and Safety of a Combined Measles, Mumps, Rubella, Chickenpox Vaccine Compared to a Marketed Combined Vaccine, Given to Healthy Children 4 to 6 Years of Age

NCT05630846 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

801

Enrollment

INDUSTRY

Sponsor class

Conditions

Measles; Mumps; Rubella; Chickenpox
Measles

Interventions

BIOLOGICAL: Investigational MMRV(H)NS vaccine
BIOLOGICAL: Investigational MM(H)RVNS vaccine
BIOLOGICAL: Investigational M(L)M(L)R(L)V(L)NS vaccine
BIOLOGICAL: Marketed MMRV_Lot 1 and Lot 2 vaccine

Sponsor

GlaxoSmithKline